1. Ahmadnia Z, Joukar F, Hasavari F, Roushan ZA, Khalili M. Dietary Patterns and Risk of Breast Cancer in Women in Guilan Province, Iran. Asian Pac J Cancer Prev. 2016;17(4):2035-40. [
DOI:10.7314/APJCP.2016.17.4.2035] [
PMID]
2. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20):2158-68. [
DOI:10.1056/NEJMsa044278] [
PMID]
3. Frumovitz M. Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis. UpToDate Available here[Accessed 30 May 2013]. 2011.
4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [
DOI:10.3322/caac.21492] [
PMID]
5. Rahimi M, Keyhani E, Behjati F. The Relation between Exon Variations of KIT Gene and Clinical Pathological Factors of Breast Cancer. J Obstet Gynecol Cancer Res. 2020;5(4):137-48. [
DOI:10.30699/jogcr.5.4.137]
6. Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. 2004;364(9430):249-56. [
DOI:10.1016/S0140-6736(04)16674-9]
7. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
8. Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011;155(1):10-20. [
DOI:10.7326/0003-4819-155-1-201107050-00003] [
PMID] [
PMCID]
9. Ahmadipour H, Sheikhizade S. Breast and Cervical Cancer Screening in Women Referred to Urban Healthcare Centers in Kerman, Iran, 2015. Asian Pac J Cancer Prev. 2016;17(S3):143-7. [
DOI:10.7314/APJCP.2016.17.S3.143] [
PMID]
10. Nahvijou A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, Rezaei Hemami M, Akbari Sari A, et al. Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer. PloS One. 2016;11(6):e0156705. [
DOI:10.1371/journal.pone.0156705] [
PMID] [
PMCID]
11. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311(13):1327-35. [
DOI:10.1001/jama.2014.1398] [
PMID]
12. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114(2):143-5. [
DOI:10.1016/S0033-3506(00)00324-3]
13. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev. 2004;5(1):24-7.
14. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, et al. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011;378(9801):1461-84. [
DOI:10.1016/S0140-6736(11)61351-2]
15. Enayatrad M, Amoori N, Salehiniya H. Epidemiology and trends in breast cancer mortality in iran. Iran J Public Health. 2015;44(3):430-1.
16. Mokarian F, Ramezani MA, Heydari K, Tabatabaeian M, Tavazohi H. Epidemiology and trend of cancer in Isfahan 2005-2010. J Res Med Sci. 2011;16(9):1228-33.
17. Tolou-Ghamari Z. Prevalence of Breast Cancer in Isfahan Province, Iran. J Womens Health. 2018(In Press). [
DOI:10.5812/whb.82678]
18. Momenimovahed Z, Salehiniya H. Cervical cancer in Iran: integrative insights of epidemiological analysis. Biomedicine (Taipei). 2018;8(3):18. [
DOI:10.1051/bmdcn/2018080318] [
PMID] [
PMCID]
19. Daroudi R, Akbari Sari A, Nahvijou A, Kalaghchi B, Najafi M, Zendehdel K. The Economic Burden of Breast Cancer in Iran. Iran J Public Health. 2015;44(9):1225-33.
20. Peirson L, Fitzpatrick-Lewis D, Ciliska D, Warren R. Screening for cervical cancer: a systematic review and meta-analysis. Syst Rev. 2013;2(1):35. [
DOI:10.1186/2046-4053-2-35] [
PMID] [
PMCID]
21. Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, et al. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. JAMA. 2018;319(2):154-64. [
DOI:10.1001/jama.2017.19130] [
PMID] [
PMCID]